Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105085495B reveals a cost-effective one-pot method for N-alkynyl benzimidazole derivatives, ensuring high purity and supply chain reliability for global pharmaceutical manufacturers.
Patent CN108997247A discloses efficient oxidation route for Rivaroxaban intermediate enabling cost reduction in API manufacturing and supply chain reliability.
Patent CN118619916A reveals additive-free synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN102939285A reveals green cyclization for Aprepitant. Reduces toxicity and energy. Ensures high purity supply chain continuity for global buyers.
Patent CN111440151A details a streamlined 3-step synthesis of Pralsetinib using Rieke Zinc coupling, offering high purity >99.6% and reduced manufacturing costs.
Novel iodine-catalyzed method for thiobenzofuran derivatives offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101163698B reveals efficient Pd-catalyzed coupling and reductive amination routes for 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide, offering significant supply chain advantages.
Patent CN100478333C reveals a novel route for chiral bis-imidazolinylbenzene compounds using amino alcohols, offering cost-effective solutions for asymmetric catalysis ligands.
Patent CN106187657A reveals stable PdMgAl-LDH catalyst for Suzuki reactions. Reduces palladium pollution and enables scalable pharmaceutical intermediates manufacturing with cost efficiency.
Patent CN107686457B reveals a ferrous salt-catalyzed synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable manufacturing advantages.
Patent CN115353497A reveals a metal-free photocatalytic route for beta-C benzothiazole ethers, offering cost reduction and simplified purification for pharmaceutical intermediate manufacturing.
Patent CN112159380B discloses a safe, low-temperature route for Barosavir intermediates, eliminating toxic reagents and enabling cost reduction in API manufacturing.
Patent CN107827764A reveals ionic liquid catalysis for bis-beta-amino ketones. Achieve high purity and cost reduction in fine chemical manufacturing with scalable routes.
Patent CN104326987B reveals water-phase catalytic synthesis for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
New patent CN116715573B reveals high-yield synthesis route for 2 2-dimethylbutyryl chloride offering significant purity improvements and supply chain stability for pharmaceutical manufacturers.
Novel iron-catalyzed method for stereoselective synthesis of heterocyclic intermediates. Reduces heavy metal reliance and enables efficient deuterium labeling for drug development.
Novel copper catalyzed route offers high yield quinoline amides. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Novel air-stable palladium carbene synthesis offers improved stability and simplified purification for catalytic applications and reliable supply chain solutions.
Patent CN103429567A details a mild Rh-catalyzed process for chiral amino acids with >98% ee. Ideal for reliable pharmaceutical intermediate supply chains.
Patent CN102850379B details high-yield 7-MAC synthesis. Offers supply chain reliability and cost reduction for cephalosporin intermediate manufacturing.